Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning.
Loh
Su Ming Yvonne
SM
Ratnagopal
Pavanni
P
Tan
Huat Chye Patrick
HC
Goh
Yeow Tee
YT
Koh
Boon Chai Mickey
BC
Koh
Liang Piu
LP
Linn
Yeh Ching
YC
Hwang
William Ying Khee
WY
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002330:Carmustine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D020528:Multiple Sclerosis, Chronic Progressive / Q000628:therapy*; D019653:Myeloablative Agonists / Q000008:administration & dosage*; D011034:Podophyllotoxin / Q000008:administration & dosage; D012074:Remission Induction; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D019653:Myeloablative Agonists; D003561:Cytarabine; D003520:Cyclophosphamide; D014740:Vidarabine; D011034:Podophyllotoxin; C024352:fludarabine; D008558:Melphalan; D002330:Carmustine